Keith Stewart, M.B., Ch.B.

  1. Internist
  2. Hematologist

Departments

Location

  1. Phoenix, Arizona | Rochester, Minnesota

Languages

English
  1. Amyloidosis
  2. Multiple myeloma
  3. Waldenstrom macroglobulinemia
  • Myeloma
  • Waldenstroms macroglobulinemia
  • Amyloidosis
  • Drug development
  • Clinical trials
  • Correlative biology
  • Genomics

Phoenix, Arizona

Rochester, Minnesota

  1. 2002
    MBARichard Ivey School of Business, University of Western Ontario
  2. 1992
    Fellow - MRC ResearchNew England Medical Center, Boston, Massachusetts
  3. 1990
    Fellow - HematologyUniversity of Toronto
  4. 1988
    Resident - Internal MedicineQueen's University
  5. 1985
    InternshipGlasgow Royal Infirmary, Glasgow, United Kingdom
  6. 1984
    MB ChBAberdeen University Medical School, United Kingdom

Certifications

  1. 1990
    HematologyRoyal College of Physicians & Surgeons Canada
  2. 1989
    Internal MedicineRoyal College of Physicians & Surgeons Canada

Awards and honors

  1. 2015
    America's Top DoctorsCastle Connolly Medical Ltd
  2. 2014
    America's Top DoctorsCastle Connolly Medical Ltd.
  3. 2010
    Vasek and Anna Maria Polak Professor of Cancer ResearchMayo Clinic College of Medicine and Science, Department of Education Administration
  4. 2002
    Canada's Top 40 Under 40Awarding Organization
  5. 1999
    Scott-Whitmore Chair in Hematology and Gene TherapyUniversity of Toronto

Professional memberships

  1. 2014 - 2016
    MemberCommittee on Investment and Audit, American Society of Hematology
  2. 2014 - present
    MemberMedical Relations Committee, Mayo Clinic Committees
  3. 2014 - present
    MemberScientific Committee, Society of Hematologic Oncology
  4. 2012 - 2015
    MemberSpace and Capital Committee, Executive Operations Team - Arizona, Mayo Clinic Arizona Committees
  5. 2012 - 2015
    MemberClinical Practice Committee - Arizona, Executive Operations Team - Arizona, Mayo Clinic Arizona Committees
  6. 2012 - 2015
    ChairTRP Peer Review Panel: CLL, Lymphoma, Myeloma, Medical and Scientific Affairs Committee, Leukemia & Lymphoma Society
  7. 2012 - present
    MemberAdvisory Board, Myeloma UK
  8. 2011 - 2015
    MemberExecutive Operations Team - Arizona, Mayo Clinic Arizona Committees
  9. 2011 - 2015
    MemberExecutive Research Committee, Mayo Clinic Research Committee, Mayo Clinic Committees
  10. 2011 - 2015
    MemberMedical and Scientific Affairs Committee, Leukemia & Lymphoma Society
  11. 2011 - 2013
    ChairDevelopmental Therapeutics Study Section, National Cancer Institute, National Institutes of Health
  12. 2011 - present
    MemberScientific Advisory Council, Mayo Clinic Research Advisory Group, Mayo Clinic Committees
  13. 2011 - present
    MemberThe Named Professorship Committee, Mayo Clinic Board of Governors
  14. 2010 - 2015
    MemberResearch Operations Management Team, Mayo Clinic Arizona Committees
  15. 2010 - 2015
    MemberMayo Clinic Research Committee, Mayo Clinic Committees
  16. 2010 - present
    MemberDivision Chairs Meeting, Executive Operations Team - Arizona, Mayo Clinic Arizona Committees
  17. 2009 - 2012
    MemberPeer Review Panel, Myeloma UK
  18. 2009 - 2011
    MemberDevelopmental Therapeutics Study Section, National Cancer Institute, National Institutes of Health
  19. 2007 - 2012
    MemberCancer Center Committee, Executive Operations Team - Arizona, Mayo Clinic Arizona Committees
  20. 2007 - 2010
    ChairHematology Disease Oriented Group, Division of Hematology/Oncology, Department of Internal Medicine
  21. 2007 - 2010
    MemberClinical Research Subcommittee, Research Operations Management Team, Mayo Clinic Arizona Committees
  22. 2007 - present
    MemberHematology Disease Oriented Group, Division of Hematology/Oncology, Department of Internal Medicine
  23. 2006 - 2011
    MemberCollaboration and Business Development Coordination Council, Executive Operations Team - Arizona, Mayo Clinic Arizona Committees
  24. 2006 - present
    External ReviewerCancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health
  25. 2006 - present
    MemberAmerican Society of Hematology
  26. 2005 - 2006
    ChairSpecial Emphasis Panel, Subcommittee D Parent Committee, National Cancer Institute
  27. 2005 - present
    MemberAmerican Society of Clinical Oncology
  28. 2005 - present
    MemberScientific Advisory Board, International Myeloma Foundation
  29. 2004 - 2010
    MemberSteering Committee, Multiple Myeloma Research Consortium
  30. 2004 - 2006
    HeadMyeloma Site Group, Clinical Trials Group, National Cancer Institute of Canada
  31. 2002 - 2005
    MemberSubcommittee D Parent Committee, National Cancer Institute, National Institutes of Health
  32. 1999 - 2002
    MemberScientific Advisory Board, Hema-Quebec
  33. 1998 - 2001
    MemberAnimal Care Committee, Toronto Hospital
  34. 1998 - present
    MemberScientific Advisory Board, Multiple Myeloma Research Foundation
  35. 1997 - 2006
    MemberScientific Advisory Board, McCarty Cancer Foundation
  36. 1997 - 2003
    MemberGene Therapy Committee, International Society for Hematotherapy and Graft Engineering
  37. 1996 - 2008
    MemberInstitute of Medical Science, University of Toronto
  38. 1989 - present
    FellowRoyal College of Physicians and Surgeons of Canada
See more